Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. nature reviews microbiology 
3. review articles 
4. article
•  Review Article
•  Published: December 2007


An increasing threat in
hospitals: multidrug-resistant
Acinetobacter baumannii
•  Lenie Dijkshoorn
1,
•  Alexandr Nemec2 &
•  Harald Seifert3 
Nature Reviews Microbiology volume 5, pages 939–951 (2007)Cite
this article
•  37k Accesses
•  1616 Citations
•  37 Altmetric
•  Metrics details
Key Points
•  The genus Acinetobacter is a heterogeneous group of
organisms that comprises 17 named species and 15 species
that have no valid names as of yet. Acinetobacter baumannii
and the closely related genomic species 3 and 13TU are
clinically the most important species.
•  A. baumannii is a major cause of hospital-acquired infections
in patients who are critically ill. The most frequent infections
are ventilator-associated pneumonia and bloodstream
infection.
•  A. baumannii strains that are circulating in hospitals can be
multidrug resistant (MDR) and can spread epidemically. A
recent manifestation of MDR A. baumanniii is its association
with wound infection in severely injured soldiers.


•  A. baumannii has an extraordinary capacity to develop
resistance to multiple antimicrobial agents and many
resistance mechanisms have been identified in this organism.
An 86-kilobase genomic region that contains 45 resistance
genes has recently been identified in A. baumannii and
represents a unique structure that is found in human bacterial
pathogens.
•  The treatment of A. baumannii infections is often hampered
by the multidrug resistance of the causative organism, which
can affect all systemic antimicrobials, including carbapenems
and even polymyxins. Combination therapy remains the last
alternative in such cases.
•  The study of the epidemicity and pathogenicity factors of A.
baumannii is still at an elementary stage.
Abstract
Since the 1970s, the spread of multidrug-resistant (MDR)
Acinetobacter strains among critically ill, hospitalized patients, and
subsequent epidemics, have become an increasing cause of concern.
Reports of community-acquired Acinetobacter infections have also
increased over the past decade. A recent manifestation of MDR
Acinetobacter that has attracted public attention is its association
with infections in severely injured soldiers. Here, we present an
overview of the current knowledge of the genus Acinetobacter, with
the emphasis on the clinically most important species, Acinetobacter
baumannii.
 Access through your institution
Buy or subscribe
This is a preview of subscription content, access via your institution
Access options
 Access through your institution


Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Learn more
Buy this article
•  Purchase on SpringerLink
•  Instant access to full article PDF
Buy now
Prices may be subject to local taxes which are calculated during
checkout
Additional access options:
•  Log in
•  Learn about institutional subscriptions
•  Read our FAQs
•  Contact customer support
Figure 1: Amplified fragment length polymorphism (AFLP)
analysis of Acinetobacter strains.
[image]
Figure 2: Overview of the dynamics between patients, bacteria
and the hospital environment.
[image]
Figure 3: The factors that contribute to Acinetobacter baumannii
environmental persistence and host infection and colonization.
[image]
Similar content being viewed by others
[image]


Emergence and global spread of a dominant
multidrug-resistant clade within Acinetobacter
baumannii
Article Open access 21 March 2025
[image]
Investigating the prevalence of class 1, 2, and 3
integrons in carbapenem-resistant Acinetobacter
baumannii isolated from burn wound infections
Article Open access 29 August 2025
[image]
Mechanistic insights into synergy between nalidixic
acid and tetracycline against clinical isolates of
Acinetobacter baumannii and Escherichia coli
Article Open access 10 May 2021
References
1. Bergogne-Bérézin, E. & Towner, K. J. Acinetobacter spp. as
nosocomial pathogens: microbiological, clinical, and
epidemiological features. Clin. Microbiol. Rev. 9, 148–165
(1996). Comprehensive review of the epidemiology,
clinical significance, epidemiological typing and
antibiotic resistance of acinetobacters.
Article  PubMed  PubMed Central  Google Scholar 
2. Joly-Guillou, M. L. Clinical impact and pathogenicity of
Acinetobacter. Clin. Microbiol. Infect. 11, 868–873 (2005).
Article  PubMed  Google Scholar 
3. Bouvet, P. J. M. & Grimont, P. A. D. Taxonomy of the genus
Acinetobacter with the recognition of Acinetobacter baumannii
sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter


johnsonii sp. nov., and Acinetobacter junii sp. nov. and
emended descriptions of Acinetobacter calcoaceticus and
Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36, 228–240
(1986). First study to split up the genus Acinetobacter into
species.
Article  CAS  Google Scholar 
4. Gerner-Smidt, P., Tjernberg, I. & Ursing, J. Reliability of
phenotypic tests for identification of Acinetobacter species. J.
Clin. Microbiol. 29, 277–282 (1991).
CAS  PubMed  PubMed Central  Google Scholar 
5. Tjernberg, I. & Ursing, J. Clinical strains of Acinetobacter
classified by DNA–DNA hybridization. APMIS 97, 595–605
(1989). Confirmation of the taxonomy described in
reference 3 and demonstration of the high similarity of A.
calcoaceticus, A. baumannii and gen.sp. 3 and 13TU.
Article  CAS  PubMed  Google Scholar 
6. Bernards, A. T., van der Toorn, J., van Boven, C. P. &
Dijkshoorn, L. Evaluation of the ability of a commercial
system to identify Acinetobacter genomic species. Eur. J. Clin.
Microbiol. Infect. Dis. 15, 303–308 (1996).
Article  CAS  PubMed  Google Scholar 
7. van Dessel, H. et al. Outbreak of a susceptible strain of
Acinetobacter species 13 (sensu Tjernberg and Ursing) in an
adult neurosurgical intensive care unit. J. Hosp. Infect. 51,
89–95 (2002).
Article  CAS  PubMed  Google Scholar 
8. Dortet, L., Legrand, P., Soussy, C. J. & Cattoir, V. Bacterial
identification, clinical significance, and antimicrobial
susceptibilities of Acinetobacter ursingii and Acinetobacter
schindleri, two frequently misidentified opportunistic
pathogens. J. Clin. Microbiol. 44, 4471–4478 (2006).


Article  CAS  PubMed  PubMed Central  Google Scholar 
9. Gerner-Smidt, P. & Tjernberg, I. Acinetobacter in Denmark: II.
Molecular studies of the Acinetobacter calcoaceticus–
Acinetobacter baumannii complex. APMIS 101, 826–832
(1993).
Article  CAS  PubMed  Google Scholar 
10. Seifert, H., Baginski, R., Schulze, A. & Pulverer, G. The
distribution of Acinetobacter species in clinical culture
materials. Zentralbl. Bakteriol. 279, 544–552 (1993).
Article  CAS  PubMed  Google Scholar 
11. Seifert, H. et al. Distribution of Acinetobacter species on
human skin: comparison of phenotypic and genotypic
identification methods. J. Clin. Microbiol. 35, 2819–2825
(1997).
CAS  PubMed  PubMed Central  Google Scholar 
12. Berlau, J., Aucken, H., Malnick, H. & Pitt, T. Distribution of
Acinetobacter species on skin of healthy humans. Eur. J. Clin.
Microbiol. Infect. Dis. 18, 179–183 (1999).
Article  CAS  PubMed  Google Scholar 
13. Dijkshoorn, L. et al. Prevalence of Acinetobacter baumannii
and other Acinetobacter spp. in faecal samples from non-
hospitalised individuals. Clin. Microbiol. Infect. 11, 329–332
(2005).
Article  CAS  PubMed  Google Scholar 
14. La Scola, B. & Raoult, D. Acinetobacter baumannii in human
body louse. Emerg. Infect. Dis. 10, 1671–1673 (2004).
Article  PubMed  PubMed Central  Google Scholar 
15. Chu, Y. W. et al. Skin carriage of acinetobacters in Hong
Kong. J. Clin. Microbiol. 37, 2962–2967 (1999).


CAS  PubMed  PubMed Central  Google Scholar 
16. Boerlin, P., Eugster, S., Gaschen, F., Straub, R. & Schawalder,
P. Transmission of opportunistic pathogens in a veterinary
teaching hospital. Vet. Microbiol. 82, 347–359 (2001).
Article  CAS  PubMed  Google Scholar 
17. Houang, E. T. et al. Epidemiology and infection control
implications of Acinetobacter spp. in Hong Kong. J. Clin.
Microbiol. 39, 228–234 (2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
18. Berlau, J., Aucken, H. M., Houang, E. & Pitt, T. L. Isolation of
Acinetobacter spp. including A. baumannii from vegetables:
implications for hospital-acquired infections. J. Hosp. Infect.
42, 201–204 (1999).
Article  CAS  PubMed  Google Scholar 
19. Huys, G. et al. Biodiversity of chloramphenicol-resistant
mesophilic heterotrophs from Southeast Asian aquaculture
environments. Res. Microbiol. 158, 228–235 (2007).
Article  CAS  PubMed  Google Scholar 
20. Fournier, P. E. et al. Comparative genomics of multidrug
resistance in Acinetobacter baumannii. PLoS Genet. 2, e7
(2006). Description of an 86-kb genomic region that was
termed a resistance island.
Article  CAS  PubMed  PubMed Central  Google Scholar 
21. Baumann, P. Isolation of Acinetobacter from soil and water. J.
Bacteriol. 96, 39–42 (1968).
CAS  PubMed  PubMed Central  Google Scholar 
22. Seifert, H. & Gerner-Smidt, P. Comparison of ribotyping and
pulsed-field gel electrophoresis for molecular typing of
Acinetobacter isolates. J. Clin. Microbiol. 33, 1402–1407


(1995).
CAS  PubMed  PubMed Central  Google Scholar 
23. Spence, R. P. et al. Population structure and antibiotic
resistance of Acinetobacter DNA group 2 and 13TU isolates
from hospitals in the UK. J. Med. Microbiol. 51, 1107–1112
(2002).
Article  CAS  PubMed  Google Scholar 
24. Lee, J. H. et al. Differences in phenotypic and genotypic traits
against antimicrobial agents between Acinetobacter baumannii
and Acinetobacter genomic species 13TU. J. Antimicrob.
Chemother. 59, 633–639 (2007).
Article  CAS  PubMed  Google Scholar 
25. Jawad, A., Seifert, H., Snelling, A. M., Heritage, J. & Hawkey,
P. M. Survival of Acinetobacter baumannii on dry surfaces:
comparison of outbreak and sporadic isolates. J. Clin.
Microbiol. 36, 1938–1941 (1998).
CAS  PubMed  PubMed Central  Google Scholar 
26. van den Broek, P. J. et al. Epidemiology of multiple
Acinetobacter outbreaks in the Netherlands during the period
1999–2001. Clin. Microbiol. Infect. 12, 837–843 (2006). An
analysis of eight concurrent outbreaks in one country
and the measures that brought them under control.
Article  CAS  PubMed  Google Scholar 
27. Bernards, A. T. et al. Methicillin-resistant Staphylococcus
aureus and Acinetobacter baumannii: an unexpected difference
in epidemiologic behavior. Am. J. Infect. Control 26, 544–551
(1998).
Article  CAS  PubMed  Google Scholar 
28. Dijkshoorn, L., Van Vianen, W., Degener, J. E. & Michel, M. F.
Typing of Acinetobacter calcoaceticus strains isolated from


hospital patients by cell envelope protein profiles. Epidemiol.
Infect. 99, 659–667 (1987).
Article  CAS  PubMed  PubMed Central  Google Scholar 
29. Dijkshoorn, L. et al. Use of protein profiles to identify
Acinetobacter calcoaceticus in a respiratory care unit. J. Clin.
Pathol. 42, 853–857 (1989).
Article  CAS  PubMed  PubMed Central  Google Scholar 
30. Nemec, A., Janda, L., Melter, O. & Dijkshoorn, L. Genotypic
and phenotypic similarity of multiresistant Acinetobacter
baumannii isolates in the Czech Republic. J. Med. Microbiol.
48, 287–296 (1999).
Article  CAS  PubMed  Google Scholar 
31. Turton, J. F. et al. A prevalent, multiresistant clone of
Acinetobacter baumannii in Southeast England. J. Hosp. Infect.
58, 170–179 (2004).
Article  CAS  PubMed  Google Scholar 
32. Da Silva, G. J., Dijkshoorn, L., van der Reijden, T., van
Strijen, B. & Duarte, A. Identification of widespread, closely
related Acinetobacter baumannii isolates in Portugal as a
subgroup of European clone II. Clin. Microbiol. Infect. 13, 190–
195 (2007).
Article  CAS  PubMed  Google Scholar 
33. Quale, J., Bratu, S., Landman, D. & Heddurshetti, R.
Molecular epidemiology and mechanisms of carbapenem
resistance in Acinetobacter baumannii endemic in New York
City. Clin. Infect. Dis. 37, 214–220 (2003).
Article  CAS  PubMed  Google Scholar 
34. Dijkshoorn, L. et al. Comparison of outbreak and nonoutbreak
Acinetobacter baumannii strains by genotypic and phenotypic
methods. J. Clin. Microbiol. 34, 1519–1525 (1996).


CAS  PubMed  PubMed Central  Google Scholar 
35. Nemec, A., Dijkshoorn, L. & van der Reijden, T. Long-term
predominance of two pan-European clones among multi-
resistant Acinetobacter baumannii strains in the Czech
Republic. J. Med. Microbiol. 53, 147–153 (2004). A
compilation of the properties of A. baumannii strains that
belong to European clones I and II.
Article  PubMed  Google Scholar 
36. van Dessel, H. et al. Identification of a new geographically
widespread multiresistant Acinetobacter baumannii clone from
European hospitals. Res. Microbiol. 155, 105–112 (2004).
Article  CAS  PubMed  Google Scholar 
37. Seifert, H., Strate, A., Schulze, A. & Pulverer, G. Vascular
catheter-related bloodstream infection due to Acinetobacter
johnsonii (formerly Acinetobacter calcoaceticus var. lwoffii):
report of 13 cases. Clin. Infect. Dis. 17, 632–636 (1993).
Article  CAS  PubMed  Google Scholar 
38. Seifert, H., Strate, A., Schulze, A. & Pulverer, G. Bacteremia
due to Acinetobacter species other than Acinetobacter
baumannii. Infection 22, 379–385 (1994).
Article  CAS  PubMed  Google Scholar 
39. Nemec, A. et al. Acinetobacter ursingii sp. nov. and
Acinetobacter schindleri sp. nov., isolated from human clinical
specimens. Int. J. Syst. Evol. Microbiol. 51, 1891–1899 (2001).
Article  CAS  PubMed  Google Scholar 
40. Nemec, A. et al. Acinetobacter parvus sp. nov., a small-colony-
forming species isolated from human clinical specimens. Int.
J. Syst. Evol. Microbiol. 53, 1563–1567 (2003).
Article  CAS  PubMed  Google Scholar 


41. de Beaufort, A. J., Bernards, A. T., Dijkshoorn, L. & van
Boven, C. P. Acinetobacter junii causes life-threatening sepsis
in preterm infants. Acta Paediatr. 88, 772–775 (1999).
Article  CAS  PubMed  Google Scholar 
42. Garcia-Garmendia, J. L. et al. Risk factors for Acinetobacter
baumannii nosocomial bacteremia in critically ill patients: a
cohort study. Clin. Infect. Dis. 33, 939–946 (2001).
Article  CAS  PubMed  Google Scholar 
43. Wisplinghoff, H., Perbix, W. & Seifert, H. Risk factors for
nosocomial bloodstream infections due to Acinetobacter
baumannii: a case-control study of adult burn patients. Clin.
Infect. Dis. 28, 59–66 (1999).
Article  CAS  PubMed  Google Scholar 
44. Maragakis, L. L. et al. An outbreak of multidrug-resistant
Acinetobacter baumannii associated with pulsatile lavage
wound treatment. JAMA 292, 3006–3011 (2004).
Article  CAS  PubMed  Google Scholar 
45. Cisneros, J. M. et al. Bacteremia due to Acinetobacter
baumannii: epidemiology, clinical findings, and prognostic
features. Clin. Infect. Dis. 22, 1026–1032 (1996).
Article  CAS  PubMed  Google Scholar 
46. Seifert, H., Strate, A. & Pulverer, G. Nosocomial bacteremia
due to Acinetobacter baumannii. Clinical features,
epidemiology, and predictors of mortality. Medicine 74, 340–
349 (1995).
Article  CAS  PubMed  Google Scholar 
47. Siegman-Igra, Y., Bar-Yosef, S., Gorea, A. & Avram, J.
Nosocomial acinetobacter meningitis secondary to invasive
procedures: report of 25 cases and review. Clin. Infect. Dis. 17,
843–849 (1993).


Article  CAS  PubMed  Google Scholar 
48. Davis, K. A., Moran, K. A., McAllister, C. K. & Gray, P. J.
Multidrug-resistant Acinetobacter extremity infections in
soldiers. Emerg. Infect. Dis. 11, 1218–1224 (2005). Important
paper on Acinetobacter infections in wounded soldiers.
Article  PubMed  PubMed Central  Google Scholar 
49. Wise, K. A. & Tosolini, F. A. Epidemiological surveillance of
Acinetobacter species. J. Hosp. Infect. 16, 319–329 (1990).
Article  CAS  PubMed  Google Scholar 
50. Blot, S., Vandewoude, K. & Colardyn, F. Nosocomial
bacteremia involving Acinetobacter baumannii in critically ill
patients: a matched cohort study. Intensive Care Med. 29, 471–
475 (2003).
Article  PubMed  Google Scholar 
51. Garnacho, J., Sole-Violan, J., Sa-Borges, M., Diaz, E. & Rello,
J. Clinical impact of pneumonia caused by Acinetobacter
baumannii in intubated patients: a matched cohort study. Crit.
Care Med. 31, 2478–2482 (2003).
Article  PubMed  Google Scholar 
52. Falagas, M. E., Bliziotis, I. A. & Siempos, I. I. Attributable
mortality of Acinetobacter baumannii infections in critically ill
patients: a systematic review of matched cohort and case-
control studies. Crit. Care 10, R48 (2006).
Article  PubMed  PubMed Central  Google Scholar 
53. Falagas, M. E. & Rafailidis, P. I. Attributable mortality of
Acinetobacter baumannii: no longer a controversial issue. Crit.
Care 11, 134 (2007).
Article  PubMed  PubMed Central  Google Scholar 
54. Anstey, N. M. et al. Community-acquired bacteremic


Acinetobacter pneumonia in tropical Australia is caused by
diverse strains of Acinetobacter baumannii, with carriage in the
throat in at-risk groups. J. Clin. Microbiol. 40, 685–686
(2002).
Article  PubMed  PubMed Central  Google Scholar 
55. Chen, M. Z. et al. Severe community-acquired pneumonia due
to Acinetobacter baumannii. Chest 120, 1072–1077 (2001).
Article  CAS  PubMed  Google Scholar 
56. Oncul, O. et al. Hospital-acquired infections following the
1999 Marmara earthquake. J. Hosp. Infect. 51, 47–51 (2002).
Article  CAS  PubMed  Google Scholar 
57. Kennedy, P. J., Haertsch, P. A. & Maitz, P. K. The Bali burn
disaster: implications and lessons learned. J. Burn Care
Rehabil. 26, 125–131 (2005).
Article  PubMed  Google Scholar 
58. Scott, P. et al. An outbreak of multidrug-resistant
Acinetobacter baumannii–calcoaceticus complex infection in the
US military health care system associated with military
operations in Iraq. Clin. Infect. Dis. 44, 1577–1584 (2007).
Article  CAS  PubMed  Google Scholar 
59. Smith, M. G. et al. New insights into Acinetobacter baumannii
pathogenesis revealed by high-density pyrosequencing and
transposon mutagenesis. Genes Dev. 21, 601–614 (2007).
Article  CAS  PubMed  PubMed Central  Google Scholar 
60. Wisplinghoff, H., Schmitt, R., Wohrmann, A., Stefanik, D. &
Seifert, H. Resistance to disinfectants in epidemiologically
defined clinical isolates of Acinetobacter baumannii. J. Hosp.
Infect. 66, 174–181 (2007).
Article  CAS  PubMed  Google Scholar 


61. Tomaras, A. P., Dorsey, C. W., Edelmann, R. E. & Actis, L. A.
Attachment to and biofilm formation on abiotic surfaces by
Acinetobacter baumannii: involvement of a novel chaperone-
usher pili assembly system. Microbiology 149, 3473–3484
(2003).
Article  CAS  PubMed  Google Scholar 
62. Lee, J. C. et al. Adherence of Acinetobacter baumannii strains
to human bronchial epithelial cells. Res. Microbiol. 157, 360–
366 (2005).
Article  CAS  PubMed  Google Scholar 
63. Haseley, S. R., Pantophlet, R., Brade, L., Holst, O. & Brade, H.
Structural and serological characterisation of the O-antigenic
polysaccharide of the lipopolysaccharide from Acinetobacter
junii strain 65. Eur. J. Biochem. 245, 477–481 (1997).
Article  CAS  PubMed  Google Scholar 
64. Choi, C. H. et al. Acinetobacter baumannii outer membrane
protein A targets the nucleus and induces cytotoxicity. Cell
Microbiol. 30 Aug 2007 (doi: 10.1111/
j.1462-5822.2007.01041.x).
Article  CAS  Google Scholar 
65. Dorsey, C. W., Beglin, M. S. & Actis, L. A. Detection and
analysis of iron uptake components expressed by
Acinetobacter baumannii clinical isolates. J. Clin. Microbiol. 41,
4188–4193 (2003).
Article  CAS  PubMed  PubMed Central  Google Scholar 
66. Jankowski, S., Grzybek-Hryncewicz, K., Fleischer, M. &
Walczuk, M. Susceptibility of isolates of Acinetobacter
anitratus and Acinetobacter lwoffii to the bactericidal activity
of normal human serum. FEMS Microbiol. Immunol. 4, 255–
260 (1992).
Article  CAS  PubMed  Google Scholar 


67. Brade, H. & Galanos, C. Biological activities of the
lipopolysaccharide and lipid A from Acinetobacter
calcoaceticus. J. Med. Microbiol. 16, 211–214 (1983).
Article  CAS  PubMed  Google Scholar 
68. Knapp, S. et al. Differential roles of CD14 and toll-like
receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J.
Respir. Crit Care Med. 173, 122–129 (2006).
Article  CAS  PubMed  Google Scholar 
69. Perez, F. et al. Global challenge of multidrug-resistant
Acinetobacter baumannii. Antimicrob. Agents Chemother. 51,
3471–3484 (2007). State-of-the-art review on MDR A.
baumannii.
Article  CAS  PubMed  PubMed Central  Google Scholar 
70. Vila, J. et al. In vitro antimicrobial production of b-
lactamases, aminoglycoside-modifying enzymes, and
chloramphenicol acetyltransferase by and susceptibility of
clinical isolates of Acinetobacter baumannii. Antimicrob. Agents
Chemother. 37, 138–141 (1993).
Article  CAS  PubMed  PubMed Central  Google Scholar 
71. Seifert, H., Baginski, R., Schulze, A. & Pulverer, G.
Antimicrobial susceptibility of Acinetobacter species.
Antimicrob. Agents Chemother. 37, 750–753 (1993).
Article  CAS  PubMed  PubMed Central  Google Scholar 
72. Seifert, H., Stefanik, D. & Wisplinghoff, H. Comparative in
vitro activities of tigecycline and 11 other antimicrobial
agents against 215 epidemiologically defined multidrug-
resistant Acinetobacter baumannii isolates. J. Antimicrob.
Chemother. 58, 1099–1100 (2006).
Article  CAS  PubMed  Google Scholar 
73. Tankovic, J. et al. Characterization of a hospital outbreak of


imipenem-resistant Acinetobacter baumannii by phenotypic
and genotypic typing methods. J. Clin. Microbiol. 32, 2677–
2681 (1994).
CAS  PubMed  PubMed Central  Google Scholar 
74. Turner, P. J. & Greenhalgh, J. M. The activity of meropenem
and comparators against Acinetobacter strains isolated from
European hospitals, 1997–2000. Clin. Microbiol. Infect. 9,
563–567 (2003).
Article  CAS  PubMed  Google Scholar 
75. Li, J. et al. Heteroresistance to colistin in multidrug-resistant
Acinetobacter baumannii. Antimicrob. Agents Chemother. 50,
2946–2950 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
76. Peleg, A. Y. et al. Acinetobacter baumannii bloodstream
infection while receiving tigecycline: a cautionary report. J.
Antimicrob. Chemother. 59, 128–131 (2007).
Article  CAS  PubMed  Google Scholar 
77. Seward, R. J., Lambert, T. & Towner, K. J. Molecular
epidemiology of aminoglycoside resistance in Acinetobacter
spp. J. Med. Microbiol. 47, 455–462 (1998).
Article  CAS  PubMed  Google Scholar 
78. Doi, Y. et al. Spread of novel aminoglycoside resistance gene
aac(6′)-Iad among Acinetobacter clinical isolates in Japan.
Antimicrob. Agents Chemother. 48, 2075–2080 (2004).
Article  CAS  PubMed  PubMed Central  Google Scholar 
79. Vila, J., Ruiz, J., Goni, P. & Jimenez de Anta, T. Quinolone-
resistance mutations in the topoisomerase IV parC gene of
Acinetobacter baumannii. J. Antimicrob. Chemother. 39, 757–
762 (1997).


Article  CAS  PubMed  Google Scholar 
80. Huys, G. et al. Distribution of tetracycline resistance genes in
genotypically related and unrelated multiresistant
Acinetobacter baumannii strains from different European
hospitals. Res. Microbiol. 156, 348–355 (2005).
Article  CAS  PubMed  Google Scholar 
81. Heritier, C., Poirel, L. & Nordmann, P. Cephalosporinase over-
expression resulting from insertion of ISAba1 in Acinetobacter
baumannii. Clin. Microbiol. Infect. 12, 123–130 (2006).
Article  CAS  PubMed  Google Scholar 
82. Livermore, D. M. & Woodford, N. The b-lactamase threat in
Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends
Microbiol. 14, 413–420 (2006).
Article  CAS  PubMed  Google Scholar 
83. Turton, J. F. et al. The role of ISAba1 in expression of OXA
carbapenemase genes in Acinetobacter baumannii. FEMS
Microbiol. Lett. 258, 72–77 (2006).
Article  CAS  PubMed  Google Scholar 
84. Magnet, S., Courvalin, P. & Lambert, T. Resistance-
nodulation-cell division-type efflux pump involved in
aminoglycoside resistance in Acinetobacter baumannii strain
BM4454. Antimicrob. Agents Chemother. 45, 3375–3380
(2001).
Article  CAS  PubMed  PubMed Central  Google Scholar 
85. Marchand, I., Damier-Piolle, L., Courvalin, P. & Lambert, T.
Expression of the RND-type efflux pump AdeABC in
Acinetobacter baumannii is regulated by the AdeRS two-
component system. Antimicrob. Agents Chemother. 48, 3298–
3304 (2004).
Article  CAS  PubMed  PubMed Central  Google Scholar 


86. Poirel, L. & Nordmann, P. Carbapenem resistance in
Acinetobacter baumannii: mechanisms and epidemiology. Clin.
Microbiol. Infect. 12, 826–836 (2006). State-of-the-art
review on the mechanisms that are associated with the
carbapenem resistance of A. baumannii.
Article  CAS  PubMed  Google Scholar 
87. Bou, G., Cervero, G., Dominguez, M. A., Quereda, C. &
Martinez-Beltran, J. Characterization of a nosocomial
outbreak caused by a multiresistant Acinetobacter baumannii
strain with a carbapenem-hydrolyzing enzyme: high-level
carbapenem resistance in A. baumannii is not due solely to the
presence of b-lactamases. J. Clin. Microbiol. 38, 3299–3305
(2000).
CAS  PubMed  PubMed Central  Google Scholar 
88. Nemec, A., Dolzani, L., Brisse, S., Van Den, B. P. &
Dijkshoorn, L. Diversity of aminoglycoside-resistance genes
and their association with class 1 integrons among strains of
pan-European Acinetobacter baumannii clones. J. Med.
Microbiol. 53, 1233–1240 (2004).
Article  CAS  PubMed  Google Scholar 
89. Corbella, X. et al. Efficacy of sulbactam alone and in
combination with ampicillin in nosocomial infections caused
by multiresistant Acinetobacter baumannii. J. Antimicrob.
Chemother. 42, 793–802 (1998).
Article  CAS  PubMed  Google Scholar 
90. Wood, G. C., Hanes, S. D., Croce, M. A., Fabian, T. C. &
Boucher, B. A. Comparison of ampicillin-sulbactam and
imipenem-cilastatin for the treatment of acinetobacter
ventilator-associated pneumonia. Clin. Infect. Dis. 34, 1425–
1430 (2002).
Article  CAS  PubMed  Google Scholar 
91. Garnacho-Montero, J. et al. Treatment of multidrug-resistant


Acinetobacter baumannii ventilator-associated pneumonia
(VAP) with intravenous colistin: a comparison with
imipenem-susceptible VAP. Clin. Infect. Dis. 36, 1111–1118
(2003).
Article  CAS  PubMed  Google Scholar 
92. Kwa, A. L., Loh, C., Low, J. G., Kurup, A. & Tam, V. H.
Nebulized colistin in the treatment of pneumonia due to
multidrug-resistant Acinetobacter baumannii and Pseudomonas
aeruginosa. Clin. Infect. Dis. 41, 754–757 (2005).
Article  PubMed  Google Scholar 
93. Navon-Venezia, S., Leavitt, A. & Carmeli, Y. High tigecycline
resistance in multidrug-resistant Acinetobacter baumannii. J.
Antimicrob. Chemother. 59, 772–774 (2007).
Article  CAS  PubMed  Google Scholar 
94. Petrosillo, N. et al. Combined colistin and rifampicin therapy
for carbapenem-resistant Acinetobacter baumannii infections:
clinical outcome and adverse events. Clin. Microbiol. Infect.
11, 682–683 (2005).
Article  CAS  PubMed  Google Scholar 
95. Saballs, M. et al. Rifampicin/imipenem combination in the
treatment of carbapenem-resistant Acinetobacter baumannii
infections. J. Antimicrob. Chemother. 58, 697–700 (2006).
Article  CAS  PubMed  Google Scholar 
96. Pantopoulou, A. et al. Colistin offers prolonged survival in
experimental infection by multidrug-resistant Acinetobacter
baumannii: the significance of co-administration of rifampicin.
Int. J. Antimicrob. Agents 29, 51–55 (2007).
Article  CAS  PubMed  Google Scholar 
97. Montero, A. et al. Antibiotic combinations for serious
infections caused by carbapenem-resistant Acinetobacter


baumannii in a mouse pneumonia model. J. Antimicrob.
Chemother. 54, 1085–1091 (2004).
Article  CAS  PubMed  Google Scholar 
98. Dijkshoorn, L. et al. The synthetic N-terminal peptide of
human lactoferrin, hLF(1–11), is highly effective against
experimental infection caused by multidrug-resistant
Acinetobacter baumannii. Antimicrob. Agents Chemother. 48,
4919–4921 (2004).
Article  CAS  PubMed  PubMed Central  Google Scholar 
99. Dijkshoorn, L., van Harsselaar, B., Tjernberg, I., Bouvet, P. J.
& Vaneechoutte, M. Evaluation of amplified ribosomal DNA
restriction analysis for identification of Acinetobacter genomic
species. Syst. Appl. Microbiol. 21, 33–39 (1998).
Article  CAS  PubMed  Google Scholar 
100. Vaneechoutte, M. et al. Naturally transformable Acinetobacter
sp. strain ADP1 belongs to the newly described species
Acinetobacter baylyi. Appl. Environ. Microbiol. 72, 932–936
(2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
101. La Scola, B., Gundi, V. A., Khamis, A. & Raoult, D. Sequencing
of the rpoB gene and flanking spacers for molecular
identification of Acinetobacter species. J. Clin. Microbiol. 44,
827–832 (2006).
Article  CAS  PubMed  PubMed Central  Google Scholar 
102. Bernards, A. T., Harinck, H. I., Dijkshoorn, L., van der
Reijden, T. & van den Broek, P. J. Persistent Acinetobacter
baumannii? Look inside your medical equipment. Infect.
Control Hosp. Epidemiol. 25, 1002–1004 (2004).
Article  CAS  PubMed  Google Scholar 
103. Villegas, M. V. & Hartstein, A. I. Acinetobacter outbreaks,


1977–2000. Infect. Control Hosp. Epidemiol. 24, 284–295
(2003).
Article  PubMed  Google Scholar 
104. Weernink, A., Severin, W. P., Tjernberg, I. & Dijkshoorn, L.
Pillows, an unexpected source of Acinetobacter. J. Hosp. Infect.
29, 189–199 (1995).
Article  CAS  PubMed  Google Scholar 
105. Nishimura, Y., Ino, T. & Iizuka, H. Acinetobacter radioresistens
sp. nov. isolated from cotton and soil. Int. J. Syst. Bacteriol.
38, 209–211 (1988).
Article  Google Scholar 
106. Carr, E. L., Kämpfer, P., Patel, B. K., Gurtler, V. & Seviour, R.
J. Seven novel species of Acinetobacter isolated from activated
sludge. Int. J. Syst. Evol. Microbiol. 53, 953–963 (2003).
Article  CAS  PubMed  Google Scholar 
107. Vaneechoutte, M. et al. Oil-degrading Acinetobacter strain
RAG-1 and strains described as 'Acinetobacter venetianus sp.
nov.' belong to the same genomic species. Res. Microbiol. 150,
69–73 (1999).
Article  CAS  PubMed  Google Scholar 
108. Bouvet, P. J. & Jeanjean, S. Delineation of new proteolytic
genomic species in the genus Acinetobacter. Res. Microbiol.
140, 291–299 (1989).
Article  CAS  PubMed  Google Scholar 
109. Hujer, K. M. et al. Identification of a new allelic variant of the
Acinetobacter baumannii cephalosporinase, ADC-7 b-lactamase:
defining a unique family of class C enzymes. Antimicrob.
Agents Chemother. 49, 2941–2948 (2005).
Article  CAS  PubMed  PubMed Central  Google Scholar 


110. Devaud, M., Kayser, F. H. & Bachi, B. Transposon-mediated
multiple antibiotic resistance in Acinetobacter strains.
Antimicrob. Agents Chemother. 22, 323–329 (1982).
Article  CAS  PubMed  PubMed Central  Google Scholar 
111. Paul, G., Joly-Guillou, M. L., Bergogne-Bérézin, E., Nevot, P.
& Philippon, A. Novel carbenicillin-hydrolyzing b-lactamase
(CARB-5) from Acinetobacter calcoaceticus var. anitratus. FEMS
Microbiol. Lett. 50, 45–50 (1989).
CAS  PubMed  Google Scholar 
112. Poirel, L. et al. Identification of the novel narrow-spectrum b-
lactamase SCO-1 in Acinetobacter spp. from Argentina.
Antimicrob. Agents Chemother. 51, 2179–2184 (2007).
Article  CAS  PubMed  PubMed Central  Google Scholar 
113. Vila, J., Navia, M., Ruiz, J. & Casals, C. Cloning and
nucleotide sequence analysis of a gene encoding an OXA-
derived b-lactamase in Acinetobacter baumannii. Antimicrob.
Agents Chemother. 41, 2757–2759 (1997).
Article  CAS  PubMed  PubMed Central  Google Scholar 
114. Navia, M. M., Ruiz, J. & Vila, J. Characterization of an
integron carrying a new class D b-lactamase (OXA-37) in
Acinetobacter baumannii. Microb. Drug Resist. 8, 261–265
(2002).
Article  CAS  PubMed  Google Scholar 
115. Lambert, T., Gerbaud, G. & Courvalin, P. Characterization of
the chromosomal aac(6′)-Ij gene of Acinetobacter sp. 13 and
the aac(6′)-Ih plasmid gene of Acinetobacter baumannii.
Antimicrob. Agents Chemother. 38, 1883–1889 (1994).
Article  CAS  PubMed  PubMed Central  Google Scholar 
116. Lambert, T., Gerbaud, G. & Courvalin, P. Transferable
amikacin resistance in Acinetobacter spp. due to a new type of


3′-aminoglycoside phosphotransferase. Antimicrob. Agents
Chemother. 32, 15–19 (1988).
Article  CAS  PubMed  PubMed Central  Google Scholar 
117. Lee, H. et al. Dissemination of 16S rRNA methylase-mediated
highly amikacin-resistant isolates of Klebsiella pneumoniae and
Acinetobacter baumannii in Korea. Diagn. Microbiol. Infect. Dis.
56, 305–312 (2006).
Article  CAS  PubMed  Google Scholar 
118. Su, X. Z., Chen, J., Mizushima, T., Kuroda, T. & Tsuchiya, T.
AbeM, an H+-coupled Acinetobacter baumannii multidrug
efflux pump belonging to the MATE family of transporters.
Antimicrob. Agents Chemother. 49, 4362–4364 (2005).
Article  CAS  PubMed  PubMed Central  Google Scholar 
Download references
Acknowledgements
A.N. has been supported by grant NR 8554-3 from the Internal
Grant Agency of the Ministry of Health of the Czech Republic. The
authors thank P. van den Broek for critical reading of the
manuscript and helpful discussions and are grateful to T. van der
Reijden and other members of their laboratories for their support.
Author information
Authors and Affiliations
1. Department of Infectious Diseases C5-P, Leiden University
Medical Centre, Albinusdreef 2, P.O. BOX 9600, RC, 2300,
Leiden, the Netherlands
Lenie Dijkshoorn


2. Centre of Epidemiology and Microbiology, National Institute
of Public Health, Srobarova 48, 10042, Prague, Czech
Republic
Alexandr Nemec
3. Institute for Medical Microbiology, Immunology and Hygiene,
University of Cologne, Goldenfelsstrasse 19–21, 50935,
Cologne, Germany
Harald Seifert
Authors
1. Lenie Dijkshoorn
View author publications
Search author on:PubMed Google Scholar
2. Alexandr Nemec
View author publications
Search author on:PubMed Google Scholar
3. Harald Seifert
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to Lenie Dijkshoorn.
Related links
Related links
DATABASES
Entrez Genome Project


Acinetobacter baumannii
Pseudomonas aeruginosa
Staphylococcus aureus
Entrez Protein
AbOmpA
FURTHER INFORMATION
Acinetobacter baumannii and other pathogens in injured soldiers
Acinetobacter baumannii MLST database Institut Pasteur, Paris, FR
Acinetobacter baumannii MLST databases University Oxford, UK
ARDRA for Acinetobacter species identification
Dutch working party on infection prevention (WIP)
Glossary
DNA–DNA hybridization
Determines the degree of similarity between the genomic
DNA of two bacterial strains; the gold standard to assess
whether organisms belong to the same species.
Pandrug-resistant
In this Review, refers to A. baumannii that are resistant to
all available systemic anti-A. baumannii antimicrobial
agents, except for polymyxins.
Isolate
A population of bacterial cells in pure culture that is
derived from a single colony.


Endemic
The constant presence of an infectious agent in a given
geographical area or hospital.
Clones
A group of bacteria that were isolated independently from
different sources in time and space, but share so many
identical traits that it is likely that they evolved from a
common ancestor.
Typing method
A tool that differentiates bacterial strains below the species
level.
Ribotyping
A typing method in which chromosomal DNA is digested by
restriction enzymes, fragments are separated by
electrophoresis and, finally, particular fragments are
detected by labelled rRNA probes to generate DNA-banding
patterns, which allows the differentiation of bacterial
isolates.
Macrorestriction analysis
A typing method in which chromosomal DNA is digested
with rare-cutting enzymes, so creating large fragments that
are separated in an alternating electric field (pulsed-field
electrophoresis) according to their size.
Osteomyelitis
An infection of bone or bone marrow.
Quorum sensing
The phenomenon whereby the accumulation of signalling
molecules enables a single cell to sense the number of
bacteria (cell density) that are present, which allows


bacteria to coordinate certain behaviours or actions.
Strict isolation
Rigorous separation to prevent highly contagious or
virulent agents that can spread both by air and contact.
Contact isolation
The separation of colonized or infected individuals from
others to prevent, or limit, the direct or indirect
transmission of diseases that are spread primarily by close
or direct contact.
Minimum inhibitory concentration
The lowest concentration of an antibiotic that inhibits
visible growth of the organism.
Clinical breakpoint
A discriminatory antimicrobial concentration that is used to
interpret the results of susceptibility testing and to define
bacterial populations as susceptible, intermediate or
resistant based on the likelihood of therapeutic success.
Rights and permissions
Reprints and permissions
About this article
Cite this article
Dijkshoorn, L., Nemec, A. & Seifert, H. An increasing threat in
hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev
Microbiol 5, 939–951 (2007). https://doi.org/10.1038/nrmicro1789


Download citation
•  Issue date: December 2007
•  DOI: https://doi.org/10.1038/nrmicro1789
Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  Effectiveness of wastewater treatment plant at
the removal of nutrients, pathogenic bacteria,
and antibiotic-resistant bacteria in wastewater
from hospital source
○  Grace O. Owojori
○  Suraju A. Lateef
○  Godson R. E. E. Ana
Environmental Science and Pollution Research (2024)
•  Detection of Bacterial Pathogens from the
Pneumonic Lungs of Sheep and Goats and Their
Antimicrobial Sensitivity Pattern
○  Shobhna Singh


○  Gauri Chandratre
○  Gulshan Narang
Proceedings of the National Academy of Sciences, India Section
B: Biological Sciences (2024)
•  Risk factors and effect on mortality of
superinfections in a newly established COVID-19
respiratory sub-intensive care unit at University
Hospital in Rome
○  Alessandra Iacovelli
○  Alessandra Oliva
○  Paolo Palange
BMC Pulmonary Medicine (2023)
•  Targeting multi-drug-resistant Acinetobacter
baumannii: a structure-based approach to
identify the promising lead candidates against
glutamate racemase
○  Ankit Kumar
○  Ekampreet Singh
○  Amit Kumar Singh
Journal of Molecular Modeling (2023)
•  Droperidol as a potential inhibitor of acyl-
homoserine lactone synthase from A. baumannii:
insights from virtual screening, MD simulations
and MM/PBSA calculations
○  Rajat Kumar Jha
○  Ekampreet Singh
○  Amit Kumar Singh
Molecular Diversity (2023)


 Access through your institution
Buy or subscribe
Advertisement
[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Current issue
•  Collections
•  Follow us on Facebook
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Aims & Scope
•  Journal Information
•  Editorial policies
•  About the Editors
•  Reviews Cross-Journal Editorial Team
•  Journal Credits
•  Editorial input and checks
•  Editorial Values Statement
•  Journal Metrics
•  Publishing model
•  Calendars
•  Conferences
•  Posters
•  Web Feeds


•  Contact
Publish with us
•  For Authors
•  For Referees
•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Nature Reviews Microbiology (Nat Rev Microbiol)
ISSN 1740-1534 (online)
ISSN 1740-1526 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases


•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index
Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development


•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India
•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


 Close
[image]
Sign up for the Nature Briefing newsletter — what matters in
science, free to your inbox daily.
Email address


Sign up
I agree my information will be processed in accordance with the
Nature and Springer Nature Limited Privacy Policy.
 Close
Get the most important science stories of the day, free in your
inbox. Sign up for Nature Briefing
[image]


